References | myasthenia-gravis

References:

Home Page:

1. Howard, James. "Clinical Overview of MG." Clinical Overview of MG. Myasthenia Gravis Foundation of America, 1 Jan. 2006. Web. 11 Dec. 2014. <http://myasthenia.org/HealthProfessionals/ClinicalOverviewofMG.aspx>.

Physiology (main, NMJ and immune system pages):

1. Jayam Trouth, Annapurni, et al. "Myasthenia gravis: a review." Autoimmune diseases 2012 (2012).

2. Feher, Joseph J. Quantitative human physiology: an introduction. Academic Press, 2012.

3. Deschenes, Michael R., Carl M. Maresh, and William J. Kraemer. "The neuromuscular junction: Structure, function, and its role in the excitation of muscle." The Journal of Strength & Conditioning Research 8.2 (1994): 103-109.

4. Khaliq, Abdul, et al. "A new 3D mass diffusion–reaction model in the neuromuscular junction." Journal of computational neuroscience 30.3 (2011): 729-745.

5. Liu, D., Y. Wang, and M. A. DeCoster. "Spectral Element Simulation of Reaction-Diffusion System in the Neuromuscular Junction." J Appl Computat Math 2.136 (2013): 2.

6. Alberts, Bruce, et al. "Molecular Biology of the Cell. New York: Garland Science; 2008." Classic textbook now in its 5th Edition (2010).

7. CharlesHendry, et al. "Function of the Immune System." Nursing Standard 27.19 (2013): 35-42. Print.

8. Williams, Andrew E. Immunology: Mucosal and Body Surface Defences. John Wiley & Sons, 2011.

Pathophysiology, Signs & Symptoms:

1. Meriggioli, Matthew N., and Donald B. Sanders. "Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity." The Lancet Neurology8.5 (2009): 475-490.

2. Alberts, Bruce, et al. "Molecular Biology of the Cell. New York: Garland Science; 2008." Classic textbook now in its 5th Edition (2010).

3. Jayam Trouth, Annapurni, et al. "Myasthenia gravis: a review." Autoimmune diseases 2012 (2012).

4. Meriggioli, Matthew N., and Donald B. Sanders. "Muscle autoantibodies in myasthenia gravis: beyond diagnosis?." (2012): 427-438.

5.Berrih-Aknin, Sonia, and Rozen Le Panse. "Myasthenia gravis: A comprehensive review of immune dysregulation and etiological mechanisms."Journal of autoimmunity (2014).

6. Feher, Joseph J. Quantitative human physiology: an introduction. Academic Press, 2012.

7. Gilhus, Nils E. "Myasthenia and the neuromuscular junction." Current opinion in neurology 25.5 (2012): 523-529.

8. Mao, Zhi-Feng, et al. "Incidence of thymoma in myasthenia gravis: a systematic review." Journal of Clinical Neurology 8.3 (2012): 161-169.

9. Khaliq, Abdul, et al. "A new 3D mass diffusion–reaction model in the neuromuscular junction." Journal of computational neuroscience 30.3 (2011): 729-745.

Clinical Repercussions:

2. Carr, Aisling S., et al. "A systematic review of population based epidemiological studies in Myasthenia Gravis." BMC neurology 10.1 (2010): 46.

3. Jaretzki, Alfred, et al. "Myasthenia gravis Recommendations for clinical research standards." Neurology 55.1 (2000): 16-23.

4. Myasthenia gravis: a manual for the health care provider. Myasthenia Gravis Foundation of America, 2008.

5. Koeppen, Bruce M., and Bruce A. Stanton. Berne & Levy Physiology. Elsevier Health Sciences, 2009.

Treatment:

1. Juel, Vern, Janice M. Massey. "Myasthenia gravis". Orphanet Journal of Rare Diseases 2.44. 2007.

2. Myasthenia gravis: a manual for the health care provider. Myasthenia Gravis Foundation of America, 2008.

3. Sathasivam, Sivakumar. "Current and emerging treatments for the management of myasthenia gravis." Therapeutics and clinical risk management7 (2011): 313.

4. Kim, Jee Young, Kee Duk Park, and David P. Richman. "Treatment of myasthenia gravis based on its immunopathogenesis." Journal of Clinical Neurology 7.4 (2011): 173-183.

5. Cea, Gabriel, et al. "Thymectomy for non-thymomatous myasthenia gravis."status and date: New, published in 10 (2013).

6. Lewis, Richard A. "Myasthenia gravis: New therapeutic approaches based on pathophysiology." Journal of the neurological sciences 333.1 (2013): 93-98.

7. Robeson, Kimberly, et al. "Is the Rituximab Response in Acetylcholine Receptor Autoantibody Myasthenia Gravis Durable?(S36. 009)." Neurology82.10 Supplement (2014): S36-009.

Quantitative Test:

1. Barohn, Richard. "The Quantitative Myasthenia Gravis (QMG) Test The Manual." Myasthenia Gravis Foundation of America, 25 Mar. 2000. Web. 11 Dec. 2014. <http://myasthenia.org/LinkClick.aspx?fileticket=9U5kP6SfCJs=&tabid=125>.

Definitions:

1. Merriam-Webster. Merriam-Webster. Web. 11 Dec. 2014. <http://www.merriam-webster.com/>.